Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-FR | Version v3-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2021-07-08 | 2021-04-27 |
| Drug Identification Number | 02024179 | 02024179 |
| Brand name | OCTOSTIM LIQ INJ. 15MCG/ML | OCTOSTIM LIQ INJ. 15MCG/ML |
| Common or Proper name | Desmopressin Acetate Injection | Desmopressin Acetate Injection |
| Company Name | FERRING INC | FERRING INC |
| Ingredients | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE |
| Strength(s) | 15MCG | 15MCG |
| Dosage form(s) | LIQUID SOLUTION | LIQUID SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
| Packaging size | Cartons of 10 ampoules | Cartons of 10 ampoules |
| ATC code | H01BA | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2021-04-30 | 2021-04-30 |
| Actual discontinuation date | 2021-04-29 | |
| Remaining supply date | 2021-04-29 | 2021-04-30 |
| Discontinuation status | Reversed | To be discontinued |
| Discontinuation decision reversal | yes | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | For patients, please discuss alternative treatment options with your health care professional. | For patients, please discuss alternative treatment options with your health care professional. |
| Health Canada comments |